ELUT

Elutia Inc.

• Reuters·03/17 12:04

  Elutia to present and hold investor meetings at Sidoti Small-Cap Virtual Investor Conference

• TipRanks·03/15 06:00

  Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win

• TipRanks·03/13 12:11

  Elutia announces grants of inducement awards

• Reuters·03/13 12:01

  Elutia grants 460,000 inducement stock options under 2026 Inducement Award Plan

• Reuters·03/13 12:00

  ELUTIA ANNOUNCES GRANTS OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·03/13 00:04

  Aziyo Biologics Earnings Call: Cash, Risk and 41X

• TipRanks·03/12 13:10

  Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Stryker (SYK) and Elutia (ELUT)

• Seeking Alpha·03/12 00:22

  Elutia outlines launch timeline for NXT-41x in $1.5B breast reconstruction market while strengthening leadership team

• Reuters·03/11 20:26

  Elutia Q4 revenue rises on higher cardiovascular product sales

• Seeking Alpha·03/11 20:13

  Elutia GAAP EPS of $1.48 beats by $1.62, revenue of $3.3M in-line

• Dow Jones·03/11 20:10

  *Elutia Sees FDA Clearance in 2H of 2026 and Full NXT-41x Clearance in 1H of 2027

• Dow Jones·03/11 20:10

  *Elutia 4Q EPS $1.48 >ELUT

• Dow Jones·03/11 20:10

  *Elutia: Base Biologic Matrix NXT-41 Submitted to FDA

• Dow Jones·03/11 20:10

  *Elutia 4Q Sales $3.27M >ELUT

• Benzinga·03/11 20:09

  Elutia Q4 EPS $(0.14), Inline, Sales $3.271M Miss $3.300M Estimate